Skip to main content
. 2017 Dec 6;8(68):113090–113104. doi: 10.18632/oncotarget.23028

Table 1. Bax and Bad to Bcl-2 ratios in U251 and T98G cell line.

Cell line Treatment Bax/Bcl-2 Bad/Bcl-2 P value (vs control)
U251 TMZ 16.09 ± 2.5 11.8 ± 3.6 0.05
MET 28.8 ± 3.6 26.4 ± 2.6 0.05
TMZ + MET 58.6 ± 2.5 35.6 ± 2.5 0.001
T98G TMZ 9 ± 1.5 10.0 ± 2.2 0.05
MET 9 ± 2.2 8.0 ± 1.8 0.05
TMZ+MET 18 ± 3.0 20.0 ± 2.6 0.05

TMZ + MET vs single treatments p < 0.001

Data are expressed as mean ± SD.